Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase I trial is studying the side effects and best dose of topotecan in
treating patients with gynecologic cancer that cannot be removed by surgery.